Clinical trial
An Open-Label, Two-Arm (DefenCath® vs. Institutional Standard of Care) Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to Less Than 18 Years of Age With Kidney Failure Receiving Hemodialysis Via a Central Venous Catheter
NCT06714864 is registered in ClinicalTrials.gov with CorMedix Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Two-Arm (DefenCath® vs. Institutional Standard of Care) Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to Less Than 18 Years of Age With Kidney Failure Receiving Hemodialysis Via a Central Venous Catheter
- Lead sponsor
- CorMedix Therapeutics
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- July 8, 2025
- Completion date
- April 30, 2029
- Enrollment
- 36 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.